Clinical Trials in Georgia

Showing 13441-13460 of 19,050 trials

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

NCT01953874

The aim of the study is to compare the effects of MV targeted ASV in addition to optimized medical therapy versus optimized medical therapy alone at 6 months in patients with acute decompensated HF. The study will also assess changes in functional parameters, biomarkers, quality of life (QOL), and sleep.

Acute Decompensated Heart FailureSleep Disordered Breathing

ResMed126 participantsStarted Dec 2013

Huntsville, Alabama, United States • Los Angeles, California, United States • Denver, Colorado, United States +12 more locations

COMPLETEDPhase 314 miles

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

NCT00088179

During a heart bypass procedure, a substance called "complement" is activated by the body. This "complement activation" causes an inflammatory response that can lead to side affects such as chest pain, heart attacks, stroke, heart failure, or death. The purpose of this study is to find out if the study drug (pexelizumab), that blocks "complement activation," can reduce such side effects and be given safely to patients requiring the bypass procedure with the use of the heart-lung machine.

Coronary Artery Disease

Alexion Pharmaceuticals, Inc.4,000 participantsStarted Jul 2004

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +185 more locations

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Find Trials by Condition in Georgia

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Early Diagnosis of Pulmonary Nodules

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Dropless vs. Standard Drops Contralateral Eye Study

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Third International Study on Mechanical Ventilation

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

A Study Evaluating MM-310 in Patients With Solid Tumors

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Telotristat Etiprate for Carcinoid Syndrome Therapy

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia